Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -3,918 | N/A | -17,485 | 0 |
| Depreciation Amortization | N/A | 4 | N/A | 4 | 0 |
| Accounts receivable | N/A | -45 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -1,001 | N/A | N/A | N/A |
| Other Working Capital | N/A | -1,026 | N/A | 1,218 | 0 |
| Other Operating Activity | 0 | 1,407 | 0 | 13,739 | 0 |
| Operating Cash Flow | $N/A | $-4,579 | $N/A | $-2,524 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -15 | N/A | 3 | 0 |
| Investing Cash Flow | $N/A | $-15 | $N/A | $3 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 41,856 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,940 | 0 |
| Financing Cash Flow | $N/A | $41,856 | $N/A | $1,940 | $0 |
| Beginning Cash Position | N/A | 137 | N/A | 718 | 0 |
| End Cash Position | N/A | 37,399 | N/A | 137 | 0 |
| Net Cash Flow | $N/A | $37,262 | $N/A | $-581 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -4,579 | N/A | -2,524 | 0 |
| Capital Expenditure | N/A | -15 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -4,594 | 0 | -2,524 | 0 |